High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Blood

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V90.3.1217.1217_1217_1225PMID 9242555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wilms tumor gene expression in acute myeloid leukemias.

  1997cited by this paper
• The WT1 Wilms' tumor suppressor gene: how much do we really know?

  1996cited by this paper
• Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels.

  1996cited by this paper
• Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.

  1996cited by this paper
• Mutations in the Wilms' tumor gene WT1 in leukemias.

  1996cited by this paper
• The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR.

  1995cited by this paper
• Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.

  1995cited by this paper
• Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.

  1995cited by this paper
• Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow.

  1995cited by this paper
• Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemia.

  1995cited by this paper
• Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.

  1995cited by this paper
• Expression of the WT1 Wilms' tumor gene by normal and malignant human melanocytes

  1994cited by this paper
• Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.

  1994cited by this paper
• WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.

  1994cited by this paper
• The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.

  1994cited by this paper
• Molecular mechanisms possibly affecting WT1 function in human ovarian tumors

  1994cited by this paper
• Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells.

  1994cited by this paper
• The Wilms' tumor suppressor gene WT1 is negatively autoregulated.

  1994cited by this paper
• Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells.

  1994cited by this paper
• Cytogenetics and oncogenes in leukemia.

  1994cited by this paper
• A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys‐Drash syndrome

  1993cited by this paper
• Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.

  1993cited by this paper
• WT-1 is required for early kidney development.

  1993cited by this paper
• Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.

  1993cited by this paper
• Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis.

  1993cited by this paper
• The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.

  1993cited by this paper
• Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

  1992cited by this paper
• WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.

  1992cited by this paper
• Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.

  1992cited by this paper
• RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.

  1992cited by this paper
• Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.

  1992cited by this paper
• Expression of the Wilms' tumor gene (WT1) in human leukemias.

  1992cited by this paper
• Transcriptional repression mediated by the WT1 Wilms tumor gene product.

  1991cited by this paper
• Alternative splicing and genomic structure of the Wilms tumor gene WT1.

  1991cited by this paper
• Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

  1990cited by this paper
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

  1990cited by this paper
• The candidate Wilms' tumour gene is involved in genitourinary development

  1990cited by this paper
• Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY).

  1989cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper
• Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

  1985cited by this paper
• Enzymatic amplification of ?-globin genomic sequences and restriction site analysis for diagnosis of

  1985cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper
• Changes in size and secondary structure of the ribosomal transcription unit during vertebrate evolution.

  1975cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer

  2025cites this paper
• Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells

  2025cites this paper
• Sophoraflavanone G from Phit-Sanat (Sophora Exigua Craib) inhibits WT1 protein expression and induces cell cycle arrest and apoptosis in acute myeloid leukemia

  2025cites this paper
• RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid Leukemia

  2025cites this paper
• Assessment of the carcinogenic potential of particulate matter generated from 3D printing devices in Balb/c 3T3-1-1 cells

  2024cites this paper
• Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

  2024cites this paper
• Vaccines: a promising therapy for myelodysplastic syndrome

  2024cites this paper
• Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center

  2024cites this paper
• Wilms’ Tumor 1 Gene Expression as a Predictive Marker for Clinical Outcome of Acute Myeloid Leukemia in Iraqi Population: A Prospective Study

  2024cites this paper
• A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges

  2023cites this paper
• Prognostic significance of the Geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia.

  2023cites this paper
• High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk

  2023influential citation
• Prognostic value of the WT-1 gene combined with recurrent cytogenetic genes in acute myeloid leukemia

  2023cites this paper
• First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience

  2022cites this paper
• The Role of Wilms’ Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia

  2022cites this paper
• Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate

  2022cites this paper
• Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinoma

  2021cites this paper
• Galinpepimut-S (GPS): an investigational agent for the treatment of acute myeloid leukemia

  2021cites this paper
• Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis

  2021cites this paper
• WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes

  2021cites this paper
• WT1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML)

  2020cites this paper
• Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

  2020cites this paper
• A HIF-1 network reveals characteristics of epithelial-mesenchymal transition_11311-926556_Pattini

  2020cites this paper
• WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target

  2020cites this paper
• Antileukemic Cell Proliferation of Active Compounds from Kaffir Lime (Citrus hystrix) Leaves

  2020cites this paper
• A Risk-Scoring System to Predict Heart Failure Onset during Treatment of Myelodysplastic Syndrome with Azacitidine

  2019influential citation
• A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics.

  2019cites this paper
• Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients

  2019influential citation
• Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies.

  2019cites this paper
• Dietary Turmeric Bisdemethoxycurcumin Suppresses Wilms’ Tumor 1 and CD34 Protein Expressions in KG-1a Leukemic Stem Cells

  2019cites this paper
• Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?

  2019cites this paper
• WT1 mRNA level reflects disease changes and progression of myelodysplastic syndromes patients with ‘stable disease’

  2019cites this paper
• Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia

  2019cites this paper
• Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications

  2019cites this paper
• Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study.

  2019cites this paper
• Regulation of non-coding RNAs by phytochemicals for cancer therapy

  2019cites this paper
• MicroRNA regulation of natural killer cell development and function in leukemia.

  2019cites this paper
• Dynamic changes in the level of WT1 as an MRD marker to predict the therapeutic outcome of patients with AML with and without allogeneic stem cell transplantation.

  2019cites this paper
• 骨髓增生异常综合征患者去甲基化治疗后WT1 mRNA水平的变化及其预后意义

  2019cites this paper
• New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data

  2019influential citation
• DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and −KTS isoforms—From initial observations to recent global genomic analyses

  2018cites this paper
• A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.

  2018cites this paper
• Anti-cancer vaccine therapy for hematologic malignancies: An evolving era.

  2018cites this paper
• Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice

  2018cites this paper
• Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia

  2018cites this paper
• WT1 protein is cleaved by caspase-3 in apoptotic leukemic cells

  2018cites this paper
• Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells

  2018cites this paper
• Efficacy of Chemotherapy in Acute Leukemia Patients Resistant to Previous Standard Treatment According to the Series Measurement of WT1 Gene Expression

  2018influential citation
• Développement d’un modèle murin syngénique et immun de leucémie aiguë myéloïde et de maladie résiduelle mesurable surexprimant ou non le gène Wilms Tumor 1

  2018cites this paper
• Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells

  2018cites this paper
• Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis

  2017cites this paper
• Acute myeloid leukemia targets for bispecific antibodies

  2017cites this paper
• Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR

  2017cites this paper
• Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia

  2017cites this paper
• Distinct global binding patterns of the Wilms tumor gene 1 (WT1) −KTS and +KTS isoforms in leukemic cells

  2017cites this paper
• Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients

  2017cites this paper
• Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.

  2017cites this paper
• Heterogeneity of human WT1 gene.

  2017cites this paper
• Functional characterisation of tumour-specific T cell responses in pancreatic cancer

  2017cites this paper
• Challenges in vaccine therapy in hematological malignancies and strategies to overcome them

  2016cites this paper
• Digital gene expression profiling analysis of childhood acute lymphoblastic leukemia.

  2016cites this paper
• WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review)

  2016cites this paper
• Automated analysis of acute myeloid leukemia minimal residual disease using a support vector machine

  2016cites this paper
• Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation

  2016cites this paper
• Significance of Wilms’ tumor gene 1 as a biomarker in acute leukemia and solid tumors

  2016cites this paper
• Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia

  2016cites this paper
• STUDY OF ALTERNATIVE WILMS TUMOR GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA.

  2016cites this paper
• Hypoxia Enhances Wilm's Tumor 1 and Vascular Endothelial Growth Factor Isoform Expression in Leukemia Cells

  2016influential citation
• Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome

  2016cites this paper
• Wilms’ tumour antigen 1 Immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation: a Phase II non-randomised clinical trial (WIN)

  2016cites this paper
• Clinical Impact of Overexpression of FOXP3 and WT1 on Disease Outcome in Egyptian Acute Myeloid Leukemia Patients

  2016influential citation
• WT1 Mutation in Childhood Cancer.

  2016cites this paper
• T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells

  2015cites this paper
• HbF in HbE/β-thalassemia: A clinical and laboratory correlation

  2015cites this paper
• A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia

  2015cites this paper
• Wilms Tumor 1 rs16754 predicts favorable clinical outcomes for acute myeloid leukemia patients in South Chinese population.

  2015cites this paper
• Wilms' tumor gene 1 in different types of cancer

  2015cites this paper
• WT1 role in mammary gland and breast cancer biology

  2015cites this paper
• Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis

  2015cites this paper
• Immunotherapy Targeting Leukemia Stem Cells

  2015cites this paper
• T cell‐based targeted immunotherapies for patients with multiple myeloma

  2015cites this paper
• WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides

  2015cites this paper
• A1/Bcl2a1/BFL1 function in leukocyte development and tumorigenesis

  2015cites this paper
• Trial Watch: Peptide-based anticancer vaccines

  2015cites this paper
• Prognostic importance of expression of the Wilms’ tumor 1 gene in newly diagnosed acute promyelocytic leukemia

  2015cites this paper
• New Insight Towards Prognosis in Pediatric Acute Myeloid Leukemia: Comparative Study.

  2015cites this paper
• Enhancement of Efficacy of Wilms’ Tumor Gene WT1 Product-derived Peptide Cancer Vaccine by Co-administration with Immunopotentiating Agents: Lessons from Mouse Models

  2015cites this paper
• WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors

  2015cites this paper
• A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia

  2014cites this paper
• Surface Enhanced Raman Spectroscopy-Based Method for Leukemia Biomarker Detection Using Magnetic Core @ Gold Shell Nanoparticles

  2014cites this paper
• WT1 Overexpression Affecting Clinical Outcome in Non-Hodgkin Lymphomas and Adult Acute Lymphoblastic Leukemia

  2014cites this paper
• Impacto de las alteraciones moleculares en el pronóstico de la Leucemia Mieloide Aguda (LMA) "de novo"

  2014cites this paper
• Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels

  2014influential citation
• Prognostic factors for acute myeloid leukaemia in adults – biological significance and clinical use

  2014cites this paper
• Antibody therapy for acute myeloid leukaemia

  2014cites this paper
• The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group

  2014cites this paper
• Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation

  2014cites this paper
• The many facets of WT1 in acute myeloid leukemia: clarity remains elusive

  2014cites this paper
• Autophagy and antigen processing : strategies to enhance T cell recognition of cancer cells

  2014cites this paper
• Overview of Therapy and Strategies for Optimizing Outcomes in De Novo Pediatric Acute Myeloid Leukemia

  2014cites this paper